‘AI Bubble’ Canary Meets Coalmine – CoreWeave Reportedly Drastically Downsizes IPO Size
If ever there was a canary in the coalmine for signs of peak bubbliciousness, it is/was the CoreWeave IPO.
This IPO is a total disaster: NVDA forced to step in and “anchor” the IPO with a $250MM order at $40 per CNBC
Without NVDA, which already owns 5% of CRWV, IPO would bust https://t.co/GS9rPpneGb
— zerohedge (@zerohedge) March 27, 2025
The spinoff from Nvidia is a specialized cloud computing company that provides high-performance, GPU-accelerated infrastructure tailored for AI and machine learning workloads, operating a growing network of data centers across the United States and Europe to support its services.
In other words, it’s right at the heart of the supposed CapEx boom.
But, Semafor’s Liz Hofman reports this morning that the IPO valuation has been drastically downsized:
Scoop: CoreWeave is planning to downsize its IPO and cut the price — I’m hearing closer to the $23B valuation it had in the private market a year ago than the ~$30B it wanted.
— Liz Hoffman (@lizrhoffman) March 27, 2025
Additionally, they have reduced the IPO size to around $1.5 billion (from around $3 billion).
Here’s the potential problem, as we detailed previously:
CoreWeave has been compared to WeWork because its tremendous revenue growth has come at the expense of unsustainable capex and cash burn, which in turn require tremendous constant outside investment (or debt): CoreWeave burned nearly $6 billion of cash in 2024 and $1.1 billion the previous year, because of the massive capex to build out its AI infrastructure.
Not surprisingly, CoreWeave – which also counts Microsoft as its largest customer – has been frequently rumored to be a core spoke in revenue roundtripping schemes involving Microsoft, Nvidia and OpenAi.
I hope this helps to understand how Microsoft and Nvidia used CoreWeave (and many other start-ups the pair invested in) to round-trip revenues and inflate their business performances$MSFT $NVDA https://t.co/SVsq5SxxkF pic.twitter.com/plH5DE1vkI
— JustDario
(@DarioCpx) March 4, 2025
The Cowen report comes just days after speculation emerged that Coreweave is rushing to complete its massive IPO to cover up the the fact that Microsoft, which accounts for a majority of CoreWeave’s revenue, recently passed on a $12 billion option for compute with the company; as Semafor reported, that compute slot was then promptly filled by OpenAI, (which of course is largely funded by Microsoft).
This is a little idiosyncratic — lots of Qs about CoreWeave’s reliance on Microsoft — but also a tough backdrop. Hedge funds are down on the year, growth stocks are getting pummeled, etc. But a bad sign for the AI economy.
— Liz Hoffman (@lizrhoffman) March 27, 2025
As Semafor writes, CoreWeave’s public-market debut isn’t just a closely watched bellwether for AI, but for the IPO market overall, which has been in a deep freeze.
For now, NVDA shares are unmoved by the report (did everyone know yesterday?)
Tick tock on this AI bubble?
Tyler Durden Thu, 03/27/2025 – 09:06
Source: https://freedombunker.com/2025/03/27/ai-bubble-canary-meets-coalmine-coreweave-reportedly-drastically-downsizes-ipo-size/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
